Safety and Efficacy of Ultrasound Guided Vascular Access

Vascular Access Clinical Trial

Official title:

Safety and Efficacy of Ultrasound Guided Vascular Access

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05118581
• Other study ID #: Soh-Med-21-10-25
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 1, 2021
• Est. completion date: December 30, 2022

Study information

• Verified date: October 2021
• Source: Sohag University
• Contact: Mostafa M Ahmed, resident
• Phone: 01004115144
• Email: mostafaelsayed[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Vascular access involves central and peripheral vein accesses and arterial accesses. Central venous catheterization is widely used in clinical practice for diverse purposes, including hemodialysis for end stage renal failure, invasive hemodynamic monitoring, radiological studies, infusion of drugs that cannot be administered via peripheral vessels, administration of parenteral nutrition, vascular access in patients whose peripheral veins are difficult to be catheterized and for miscellaneous purposes that require access to large caliber vessels. Arterial cannulation is used for invasive arterial pressure monitoring and to ensure access for diagnostic and therapeutic interventions. In the United States and United Kingdom, guidelines have recommended the use of ultrasound guidance to reduce complications and improve success in central venous catheterization.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: December 30, 2022
• Est. primary completion date: December 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• · Adult patients who need vascular access (arterial or venous)

Exclusion Criteria:

• · Patients with local infection in the area targeted for vascular access.
• Patients with severe generalized infection and other skin diseases or lesions.
• patients with history of DVT of the target vein and or pulmonary embolism.
• Patients with untreated coagulopathy (INR >1.5 or platelets <50000mm3)

Related Conditions & MeSH terms

• Vascular Access

Intervention

Device:
• ultrasound guided vascular access
Arterial or venous catheterization guided by ultrasound

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of adverse effects of ultrasound guided vascular access	Number of participants with adverse effects after ultrasound guided vascular access	one year